Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 551-560 of 9365

Page
per page
  1. 5-hydroxypyrazine-2-carboxylic acid
    A3124 5-hydroxypyrazine-2-carboxylic acid
    Summary: Metabolite of pyrazinamide (PZA)
      insoluble in EtOH; ≥7 mg/mL
  2. 5-Iodotubercidin
    A3125 5-Iodotubercidin
    Target: Adenosine Kinases
    Summary: Adenosine kinase inhibitor,potent
      ≥83 mg/mL
  3. 5-R-Rivaroxaban
    A3126 5-R-Rivaroxaban
    Target: Factor Xa
    Summary: Factor Xa (FXa) inhibitor
      ≥20.85 mg/mL
  4. A 438079
    A3130 A 438079
    Summary: P2X7 receptor antagonist,competitive and selective
      Soluble in DMSO
  5. A 438079 hydrochloride
    A3131 A 438079 hydrochloride
    Summary: P2X7 receptor antagonist,competitive and selective
      ≥34.3 mg/mL
  6. A 77-01
    A3132 A 77-01
    Summary: Potent ALK5 inhibitor
      insoluble in H2O; ≥14.3 mg/mL
  7. A 83-01
    A3133 A 83-01
     10 Citation
    Summary: ALK inhibitor
      ≥21.1 mg/mL
  8. A-317491
    A3134 A-317491
    Summary: P2X3 and P2X2/3 receptor antagonist
      ≥56.6 mg/mL
  9. A-443654
    A3135 A-443654
    Summary: Akt inhibitor,potent and selective
      insoluble in H2O; ≥19.85 mg/mL
  10. A-740003
    A3136 A-740003
    Target: P2X Receptors
    Summary: P2X7 receptor antagonist
      ≥23.73 mg/mL

Items 551-560 of 9365

Page
per page